https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-05-01 / Trends Endocrinol. Metab. 2003 May-Jun;14(4):156-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-05-01 / Trends Endocrinol. Metab. 2003 May-Jun;14(4):156-622003-05-01 00:00:002019-02-15 08:53:35Dendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-04-01 / Hematology 2003 Apr;8(2):97-104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-04-01 / Hematology 2003 Apr;8(2):97-1042003-04-01 00:00:002019-02-15 08:32:45Dendritic cell-based immunotherapy for the treatment of hematological malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-02-15 / J. Immunol. 2003 Feb;170(4):1980-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-02-15 / J. Immunol. 2003 Feb;170(4):1980-62003-02-15 00:00:002019-02-15 08:50:31Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-02-01 / Clin. Breast Cancer 2003 Feb;3 Suppl 4:S158-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-02-01 / Clin. Breast Cancer 2003 Feb;3 Suppl 4:S158-632003-02-01 00:00:002019-02-15 08:50:30Fusions of breast cancer and dendritic cells as a novel cancer vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-02-01 / Expert Rev Anticancer Ther 2003 Feb;3(1):1-3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-02-01 / Expert Rev Anticancer Ther 2003 Feb;3(1):1-32003-02-01 00:00:002019-02-15 08:44:50Dendritic cell therapy of cancer: can it fulfill its promise?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-02-01 / Clin Breast Cancer 2003 Feb;3 Suppl 4:S164-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-02-01 / Clin Breast Cancer 2003 Feb;3 Suppl 4:S164-722003-02-01 00:00:002003-02-01 00:00:00HER2 dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Cancer Invest. 2003;21(6):873-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Cancer Invest. 2003;21(6):873-862003-01-01 00:00:002019-02-15 08:44:48The first 1000 dendritic cell vaccinees
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Int. J. Cancer 2003 Jan;103(1):73-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Int. J. Cancer 2003 Jan;103(1):73-832003-01-01 00:00:002020-06-23 09:43:21Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-12-01 / Cancer Biother. Radiopharm. 2002 Dec;17(6):601-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-12-01 / Cancer Biother. Radiopharm. 2002 Dec;17(6):601-192002-12-01 00:00:002019-02-15 08:44:50Advances in dendritic cell-based vaccine of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-11-01 / Int J Hyperthermia 2002 Nov-Dec;18(6):506-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-11-01 / Int J Hyperthermia 2002 Nov-Dec;18(6):506-202002-11-01 00:00:002019-02-15 08:48:26Cancer immunotherapy: stress proteins and hyperthermia
